CHIMIRRI, Alba
 Distribuzione geografica
Continente #
NA - Nord America 8.252
EU - Europa 6.524
AS - Asia 2.546
AF - Africa 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 17.358
Nazione #
US - Stati Uniti d'America 8.208
IE - Irlanda 1.814
SE - Svezia 1.540
UA - Ucraina 1.092
CN - Cina 1.010
SG - Singapore 820
DE - Germania 671
VN - Vietnam 507
FI - Finlandia 388
GB - Regno Unito 375
IT - Italia 345
IN - India 150
RU - Federazione Russa 73
CZ - Repubblica Ceca 52
CA - Canada 42
AT - Austria 41
BE - Belgio 40
FR - Francia 37
IR - Iran 24
JP - Giappone 13
NL - Olanda 10
PL - Polonia 9
CH - Svizzera 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CL - Cile 6
BG - Bulgaria 5
KR - Corea 5
TN - Tunisia 5
IL - Israele 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
EG - Egitto 3
ES - Italia 3
EU - Europa 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DZ - Algeria 2
HU - Ungheria 2
LU - Lussemburgo 2
TR - Turchia 2
AL - Albania 1
BR - Brasile 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 17.358
Città #
Jacksonville 2.073
Dublin 1.812
Chandler 1.403
Nyköping 1.010
Singapore 651
Dong Ket 505
Beijing 473
Ashburn 446
Cambridge 357
Princeton 354
Dearborn 333
Medford 300
Des Moines 270
Boardman 233
Ann Arbor 150
Lancaster 130
Woodbridge 110
Wilmington 96
Los Angeles 85
Jinan 72
Hyderabad 68
San Mateo 68
Nanjing 65
Pune 54
Messina 51
Shenyang 48
Brno 47
Vienna 41
Haikou 39
Brussels 37
Milan 33
Hebei 31
Zhengzhou 30
Houston 26
Ningbo 26
Seattle 26
Catania 25
Lappeenranta 23
Munich 23
Saint Petersburg 22
Ottawa 21
Taizhou 21
Tianjin 21
Fuzhou 20
Hangzhou 20
New York 20
Washington 20
Ardabil 19
Norwalk 19
Augusta 18
Nanchang 17
Leawood 15
Monmouth Junction 15
Taiyuan 14
Guangzhou 13
London 13
Changsha 12
Jiaxing 12
Auburn Hills 11
Edinburgh 11
Helsinki 11
Hanover 10
Clearwater 8
Montréal 8
Morikitamachi 8
Brooklyn 7
Chicago 7
Hefei 7
Kunming 7
Phoenix 7
Toronto 7
Warsaw 7
Amsterdam 6
Mcallen 6
Nicotera 6
Novokuznetsk 6
Nuremberg 6
Riva 6
Rome 6
Bremen 5
Dallas 5
Olomouc 5
Sofia 5
Tunis 5
Auckland 4
Bangalore 4
Catanzaro 4
Florence 4
Frankfurt am Main 4
Mumbai 4
Nanning 4
Saint Louis 4
Tappahannock 4
West Jordan 4
Amelia 3
Brugherio 3
Como 3
Cormeilles-en-Parisis 3
Falls Church 3
Ferrara 3
Totale 12.197
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 201
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 155
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 151
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 147
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 146
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 145
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 141
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 140
AMPA receptor antagonists: Synthesis and pharmacological evaluation 93
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 91
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 91
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 89
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 87
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 81
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 79
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 78
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 76
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 75
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 73
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 72
Anti-HIV agents: design and discovery of new potent RT inhibitors 71
Design and synthesis of acetylcholinesterase inhibitors 71
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 70
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 70
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 69
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 68
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 67
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 67
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 67
Annelated 1,5-benzothiazepines 67
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 66
Binding modes of noncompetitive AMPA antagonists: a computational approach 66
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 66
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 66
High-performance liquid chromatographic determination of new 2,3-benzodiazepines 65
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 65
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 65
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 65
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 64
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 64
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 64
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 64
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 64
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 64
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 64
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 64
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 63
Synthesis and pharmacological evaluation of new tetrahydroisoquinoline derivatives. 63
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 63
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 63
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 63
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 63
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 63
AMPA Receptor Antagonists as Potential Anticonvulsant Drugs 62
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 62
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 62
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 62
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 62
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 62
Efficient 3D Database screening for novel HIV-1 IN inhibitors 61
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 61
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 60
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 60
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 60
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 60
Electronic and conformational properties of 2,3-benzodiazepine derivatives 60
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 60
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 59
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 59
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 59
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 59
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 59
Antiretroviral strategy using multi-target agents 59
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 59
Successful optimization of human carbonic anhydrase inhibitors as neuroprotective agents 59
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 58
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 58
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 58
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 58
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 58
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 58
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 58
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 58
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 58
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 58
Design e sintesi di nuovi Antagonisti Noncompetitivi del Recettore AMPA 57
Synthesis and pharmacological properties of new 3- ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines 57
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 57
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 57
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 57
Determinatiopn of a new AMPA receptor antagonist in rat brain by HPLC 56
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 56
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 56
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 56
Synthesis, structural features and anti-HIV activity of TBZ analogues 56
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 56
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 56
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 56
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 56
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 56
Totale 7.126
Categoria #
all - tutte 71.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.889 0 0 0 0 10 319 407 341 35 314 455 8
2020/20212.634 326 3 432 89 51 310 8 277 5 276 235 622
2021/20221.911 22 339 48 59 108 9 132 76 37 25 367 689
2022/20235.684 471 420 263 419 502 616 118 341 2.258 17 217 42
2023/20241.285 109 219 85 224 120 208 24 64 2 109 34 87
2024/2025973 103 96 163 373 238 0 0 0 0 0 0 0
Totale 17.538